LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

Abstract Background The development of liver cirrhosis is usually an asymptomatic process until late stages when complications occur. The potential reversibility of the disease is dependent on early diagnosis of liver fibrosis and timely targeted treatment. Recently, the use of non-invasive tools ha...

Full description

Bibliographic Details
Main Authors: Isabel Graupera, Maja Thiele, Ann T. Ma, Miquel Serra-Burriel, Judit Pich, Núria Fabrellas, Llorenç Caballeria, Robert J. de Knegt, Ivica Grgurevic, Mathias Reichert, Dominique Roulot, Jörn M. Schattenberg, Juan M. Pericas, Paolo Angeli, Emmanuel A. Tsochatzis, Indra Neil Guha, Montserrat Garcia-Retortillo, Rosa M. Morillas, Rosario Hernández, Jordi Hoyo, Matilde Fuentes, Anita Madir, Adrià Juanola, Anna Soria, Marta Juan, Marta Carol, Alba Diaz, Sönke Detlefsen, Pere Toran, Guillem Pera, Céline Fournier, Anne Llorca, Phillip N. Newsome, Michael Manns, Harry J. de Koning, Feliu Serra-Burriel, Fernando Cucchietti, Anita Arslanow, Marko Korenjak, Laurens van Kleef, Josep Lluis Falcó, Patrick S. Kamath, Tom H. Karlsen, Laurent Castera, Frank Lammert, Aleksander Krag, Pere Ginès, for the LiverScreen Consortium investigators
Format: Article
Language:English
Published: BMC 2022-07-01
Series:BMC Public Health
Subjects:
Cirrhosis
Screening
Liver fibrosis
Chronic liver disease
NAFLD
NASH
Online Access:https://doi.org/10.1186/s12889-022-13724-6

Internet

https://doi.org/10.1186/s12889-022-13724-6

Similar Items